Market Closed -
TEL AVIV STOCK EXCHANGE
08:49:34 2024-06-09 am EDT
|
5-day change
|
1st Jan Change
|
937.1
ILa
|
0.00%
|
|
+0.68%
|
-20.11%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
69.23
|
85.28
|
91.11
|
121.2
|
71.34
|
65.12
|
Enterprise Value (EV)
1 |
102
|
132.8
|
146.1
|
195.9
|
65.09
|
64.89
|
P/E ratio
|
-7.49
x
|
-8.21
x
|
-9.38
x
|
8.26
x
|
-27.6
x
|
-8.48
x
|
Yield
|
-
|
8.51%
|
-
|
10.9%
|
-
|
-
|
Capitalization / Revenue
|
0.77
x
|
0.88
x
|
0.92
x
|
0.88
x
|
472
x
|
108
x
|
EV / Revenue
|
1.14
x
|
1.37
x
|
1.47
x
|
1.43
x
|
431
x
|
107
x
|
EV / EBITDA
|
-103
x
|
-193
x
|
21.3
x
|
7.87
x
|
-14.6
x
|
-14.1
x
|
EV / FCF
|
2.74
x
|
-39.9
x
|
22.4
x
|
-20.5
x
|
0.76
x
|
-87.5
x
|
FCF Yield
|
36.4%
|
-2.51%
|
4.47%
|
-4.88%
|
132%
|
-1.14%
|
Price to Book
|
1.18
x
|
1.81
x
|
3.13
x
|
3
x
|
2.49
x
|
3.62
x
|
Nbr of stocks (in thousands)
|
5,552
|
5,552
|
5,552
|
5,552
|
5,552
|
5,552
|
Reference price
2 |
12.47
|
15.36
|
16.41
|
21.83
|
12.85
|
11.73
|
Announcement Date
|
3/31/19
|
4/7/20
|
3/25/21
|
3/30/22
|
3/31/23
|
3/31/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
89.62
|
97.12
|
99.25
|
137
|
0.151
|
0.605
|
EBITDA
1 |
-0.986
|
-0.687
|
6.871
|
24.9
|
-4.466
|
-4.607
|
EBIT
1 |
-3.405
|
-3.01
|
4.712
|
23.08
|
-5.745
|
-4.803
|
Operating Margin
|
-3.8%
|
-3.1%
|
4.75%
|
16.85%
|
-3,804.64%
|
-793.88%
|
Earnings before Tax (EBT)
1 |
-7.647
|
-13.27
|
-8.38
|
31.82
|
-13.47
|
-8.718
|
Net income
1 |
-9.24
|
-10.39
|
-9.716
|
14.68
|
-2.589
|
-7.651
|
Net margin
|
-10.31%
|
-10.7%
|
-9.79%
|
10.72%
|
-1,714.57%
|
-1,264.63%
|
EPS
2 |
-1.664
|
-1.871
|
-1.750
|
2.644
|
-0.4663
|
-1.384
|
Free Cash Flow
1 |
37.19
|
-3.327
|
6.532
|
-9.564
|
85.71
|
-0.7414
|
FCF margin
|
41.5%
|
-3.43%
|
6.58%
|
-6.98%
|
56,763.91%
|
-122.54%
|
FCF Conversion (EBITDA)
|
-
|
-
|
95.06%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
1.308
|
-
|
2.382
|
-
|
-
|
Announcement Date
|
3/31/19
|
4/7/20
|
3/25/21
|
3/30/22
|
3/31/23
|
3/31/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
32.8
|
47.5
|
55
|
74.7
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
6.25
|
0.24
|
Leverage (Debt/EBITDA)
|
-33.27
x
|
-69.17
x
|
8.01
x
|
2.999
x
|
-
|
-
|
Free Cash Flow
1 |
37.2
|
-3.33
|
6.53
|
-9.56
|
85.7
|
-0.74
|
ROE (net income / shareholders' equity)
|
-12.2%
|
-21.8%
|
-23.9%
|
61.1%
|
-40%
|
-32.8%
|
ROA (Net income/ Total Assets)
|
-1.4%
|
-1.41%
|
2.34%
|
10.7%
|
-3.57%
|
-7.2%
|
Assets
1 |
659.7
|
738.3
|
-414.8
|
136.8
|
72.59
|
106.3
|
Book Value Per Share
2 |
10.50
|
8.470
|
5.240
|
7.280
|
5.160
|
3.240
|
Cash Flow per Share
2 |
1.470
|
3.930
|
2.750
|
1.660
|
1.210
|
0.0700
|
Capex
1 |
1.7
|
4.17
|
0.69
|
0.87
|
0.92
|
0.34
|
Capex / Sales
|
1.9%
|
4.29%
|
0.69%
|
0.64%
|
611.92%
|
56.69%
|
Announcement Date
|
3/31/19
|
4/7/20
|
3/25/21
|
3/30/22
|
3/31/23
|
3/31/24
|
|
1st Jan change
|
Capi.
|
---|
| -20.11% | 13.76M | | +2.46% | 31.61B | | +24.62% | 8.61B | | +3.86% | 7.45B | | +20.05% | 5.45B | | +23.88% | 4.07B | | -13.01% | 3.74B | | +12.91% | 3.74B | | +11.79% | 3.2B | | -9.41% | 2.73B |
Testing & Measuring Equipment
|